Fundraising Fox
Lyterian Therapeutics
South San Francisco, US · Founded 2022 · 27 employees on LinkedIn · 1 known investors
Find your way into Lyterian Therapeutics
Lyterian Therapeutics develops pharmaceutical treatments by leveraging protein homeostatic mechanisms to target genetically-validated disease drivers. The company focuses on transformative medicines for patients across multiple disease areas.
Investors · 1
The Column Grouplisted by The Column GroupSan Francisco · $30M
How we know: The Column Group's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Lyterian Therapeutics do?
- Lyterian Therapeutics develops pharmaceutical treatments by leveraging protein homeostatic mechanisms to target genetically-validated disease drivers. The company focuses on transformative medicines for patients across multiple disease areas.
- Who are Lyterian Therapeutics's investors?
- Lyterian Therapeutics's investors include The Column Group.
- Where is Lyterian Therapeutics headquartered?
- Lyterian Therapeutics is headquartered in South San Francisco, US.